首页> 外文期刊>Organization science >Safeguarding from the Sharks: Board Representation in Minority Equity Partnerships
【24h】

Safeguarding from the Sharks: Board Representation in Minority Equity Partnerships

机译:防范鲨鱼:少数股权合伙企业中的董事会代表

获取原文
获取原文并翻译 | 示例
           

摘要

We study minority equity partnerships and the representation of investing firms on the boards of directors of their partners. In such alliances, an investor firm owns a minority position in the investee partner and may or may not secure a board seat. Prior alliance governance research has largely focused on the choice between equity and nonequity forms of alliances, and it has paid little attention to the particular administrative features of these organizational forms, notably their governing boards. We extend corporate governance research that has emphasized the monitoring and advisory roles of boards by examining how an investee's concerns about knowledge misappropriation can reduce the likelihood that an investor obtains board representation. We suggest that, although there exist opportunities for an investee to benefit from the investor's advice, the investor's ability to use an investees knowledge by itself and indirectly with the help of its other partners negatively affects the likelihood of a board seat for the investor. We further argue that this negative effect is amplified when the investee has particularly valuable technologies at risk of appropriation by the investor. Our evidence from minority equity partnerships in the biopharmaceutical industry indicates why and when investors do not obtain board seats, despite the monitoring and advisory benefits that directors can bring to cooperative commercialization agreements.
机译:我们研究少数股权合伙企业以及投资公司在其合伙人董事会中的代表。在这样的联盟中,一家投资公司在被投资方的合伙人中拥有少数股份,可能会也可能不会获得董事会席位。先前的联盟治理研究主要集中在联盟股权形式和非股权形式之间的选择上,并且很少关注这些组织形式的特殊管理特征,尤其是其董事会。我们通过研究被投资方对知识盗用的担忧如何减少投资者获得董事会代表的可能性,扩展了强调董事会在监督和咨询方面作用的公司治理研究。我们建议,尽管被投资方有机会从投资方的建议中受益,但投资方本身或间接在其他合作伙伴的帮助下利用被投资方的知识的能力会对投资方获得董事会席位的可能性产生负面影响。我们进一步指出,当被投资方拥有特别有价值的技术而有被投资人侵占的风险时,这种负面影响就会加剧。我们从生物制药行业的少数股权合伙企业获得的证据表明,尽管董事可以为合作商业化协议带来监控和咨询收益,但投资者为何以及何时仍未获得董事会席位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号